Patents by Inventor David Michael Cross

David Michael Cross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for determining release of a peptide from a sustained release polylactide formulation
    Patent number: 7247491
    Abstract: A method for determining the release of a peptide from a sustained release polylactide formulation which can be carried out in a shorter time than a real-time method by accelerating the release of the peptide from the formulation. It can be used to discriminate between batches of formulations for quality control purposes and to discriminate between formulations, for example, having different drug loadings.
    Type: Grant
    Filed: October 5, 2001
    Date of Patent: July 24, 2007
    Assignee: AstraZeneca AB
    Inventors: Brian Collingwood Clark, David Michael Cross, Paul Richard Gellert, Rodney Simon Kittlety
  • Method for determining release of a peptide from a sustained release polylactide formulation
    Publication number: 20040092452
    Abstract: A method for determining the release of a peptide from a sustained release polylactide formulation which can be carried out in a shorter time than a real-time method by accelerating the release of the peptide from the formulation. It can be used to discriminate between batches of formulations for quality control purposes and to discriminate between formulations, for example, having different drug loadings.
    Type: Application
    Filed: April 8, 2003
    Publication date: May 13, 2004
    Inventors: Brian Collingwood Clark, David Michael Cross, Paul Richard Gellert, Rodney Simon Kittlety